Emami Ltd

FMCG major Emami Ltd on Thursday reported a 19 per cent year-on-year increase in its net profit for the second quarter ended September 2024 reaching Rs 213 crore, driven by improved margins and steady growth in both domestic and international markets. Revenue from operations during the quarter rose by 3 per cent to Rs 891 crore, with the domestic segment advancing by 2.6 per cent and international business growing 6 per cent, excluding a 12 per cent rise outside of Bangladesh, the company said in a statement. Gross margins for the quarter improved by 60 basis points to 70.7 per cent, reflecting strategic cost management. Earnings before interest, depreciation, tax, and amortisation (EBITDA) reached Rs 250 crore, up 7 per cent year-on-year, while EBITDA margins rose by 110 basis points to 28.1 per cent. The company during the quarter raised its stake in Helios Lifestyle, the maker of The Man Company brand, from 50.4 per cent to 98.3 per cent, reinforcing its focus on expanding its ..

In August this year, Emami acquired 100 per cent ownership of men's grooming brand The Man Company

In the driver's seat are the next generation promoters from the Agarwal and Goenka families. And they are busy mapping the next phase of growth

Homegrown FMCG major Emami Ltd on Thursday reported a 10.13 per cent rise in its profit after tax to Rs 150.6 crore for the June 2024 quarter, led by volume growth in the domestic market and expansion in margins. The company had posted a PAT of Rs 136.75 crore in the April-June quarter a year ago, according to a regulatory filing. Emami's revenue from operations was up 9.73 per cent to Rs 906.07 crore during the quarter under review. It was Rs 825.66 crore in the corresponding quarter a year ago. The company's total expenses were Rs 689.56 crore, up 8.4 per cent in the June quarter of FY24. Its total income, which includes other revenue, rose 9.9 per cent during the period under review to Rs 916.53 crore. "Domestic Business also grew by 10 per cent with a healthy volume growth of 8.7 per cent," Emami said in its earning statement. Modern trade, e-commerce and institutional channels continued to post strong growth, while general trade also rebounded to positive territory, it added

Analysts reckon Emami shall deliver a strong FY25, with near double-digit top-line growth and margin expansion

Major brands such as BoroPlus, the pain management range, the healthcare range, 7 Oils in One, The Man Company, and Brillare registered strong performance during the quarter

The management expects core brands to deliver a healthy all-round growth going forward, aided by recovery in rural areas, a strong summer and forecast of a good monsoon.

Q4FY24 company results: Alkem Laboratories, Heritage Foods, Aadhar Housing Finance, and Mazagon Dock Shipbuilder will be releasing their fourth-quarter report on May 29

FMCG major Emami Ltd on Friday reported 11.88 per cent rise in consolidated profit after tax at Rs 260.65 crore for December quarter 2023-24, helped by improvement of margins due to reduced input costs. The company had logged a net profit of Rs 232.97 crore in October-December FY23, according to a regulatory filing from Emami. Revenue from operations was up 1.38 per cent to Rs 996.32 crore during the quarter under review as against Rs 982.72 crore in the corresponding quarter. Revenue was flat in the domestic business. However, non-winter products grew 5 per cent. The international business delivered a constant currency growth of 11 per cent, said the Kolkata-headquartered firm in its earning statement. On margins, Emami said due to reduced input costs, the company experienced a noteworthy enhancement in gross margins, reaching 68.8 per cent, reflecting a substantial expansion of 290 basis points during the quarter. In December quarter, EBITDA was Rs 315 crore, higher by 7 per cen

In September, Emami announced the acquisition of a 26% stake in Axiom Ayurveda, which markets beverage products under the brand 'AloFrut'

Axiom has its own manufacturing facility in Ambala, Haryana and is setting up a fully automated new facility in Jammu (Kathua) at a cost of Rs 160 crore

The company said that with the easing of raw material cost pressure, the quarter witnessed an expansion of gross margins by 240 basis points at 65.4 per cent during the quarter

Stocks to watch on May 26, 2023: BEML, BHEL, Grasim, M&M, ONGC, Shree Renuka Sugars, Sun Pharma and Wockhardt among prominent companies scheduled to announce Q4 results on Friday.

Revenues from operations at Rs 835.95 crore in Q4FY23 was higher by 8.8 per cent from the year-ago period

The company's consolidated revenue from operation rose by 8.8 per cent to Rs 836 crore for the March quarter as compared to Rs 768 crore in the year-ago period

Meanwhile, in the past three months, the stock has shed 16 per cent, as against 4 per cent decline in the S&P BSE Sensex.

Company says gross margins shrank 230 bps in Q2FY23 due to inflationary pressures and an unfavourable portfolio mix due to extraordinary high sales of pain management products last year

Manipal Health is India's second-largest hospital chain, is estimated to have 8,700 hospital beds

The real estate arm of the diversified Emami Group has targeted retiring its long-term debt by 2023-24, which is now pegged at Rs 118 crore, a top company official said

BoI, Devyani Intl, Eveready, FSL, Mahindra Life, Paytm, REC, Siemens, Sintex, SPARC, Tata Steel, Thermax and Vijaya Diagnostics are some of the prominent companies to announce results today.